登记数据揭示翻修全髋关节置换术的并发症发生率与费用
该回顾性队列研究纳入2017至2019年27家医院的793例翻修全髋关节置换术(rTHA),分析手术指征、再入院风险及经济影响。46.3%的患者因感染就诊,感染患者再次翻修风险为非感染患者的5.6倍,感染翻修费用(17,696美元)高于非感染翻修(11,204美元),90天再入院率为21.8%。
要点
- 46.3%的翻修全髋关节置换术患者因感染就诊,感染患者再次翻修的可能性是非感染患者的5.6倍。
- 感染翻修直接费用(17,696美元)高于非感染翻修(11,204美元),两阶段翻修费用最高(37,642美元)。
- 90天再入院率为21.8%,感染翻修再入院率(13.5%)高于非感染翻修(8.3%)。
核心结论
- 髋关节翻修术,尤其是因感染进行的翻修,风险更高,并对医院系统造成重大经济影响。
- 作者认为,外科医生可利用这些数据向患者告知翻修全髋关节置换术的风险,并为改善翻修患者的报销政策进行倡导。
研究设计与样本
- 回顾性队列研究,查询一家医院系统的关节置换数据库,纳入2017至2019年间27家医院实施的793例翻修全髋关节置换术,涉及518例患者。
- 由外科医生进行病历审查以分类手术指征和翻修手术方式,收集人口统计学、住院时长、出院去向和再入院数据,并按翻修类型分析直接费用。
主要发现
- 46.3%的患者因感染就诊;感染就诊患者再次翻修的可能性是非感染患者的5.6倍。
- 感染病例住院时长(4.3天)长于非感染病例(2.4天)(P < .0001)。
- 31%的患者出院后转入专业护理机构。
- 直接费用以两阶段翻修最高(37,642美元),以衬垫翻修最低(8,979美元);感染翻修费用(17,696美元)高于非感染翻修(11,204美元)(P < .0001)。
- 90天再入院率为21.8%;感染翻修再入院(13.5%)多于非感染翻修(8.3%)。
临床怎么用
- 作者认为,外科医生可利用这些数据向患者告知翻修全髋关节置换术的风险,并为改善翻修患者的报销政策进行倡导。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Revision total hip arthroplaty (rTHA) places a burden on patients, surgeons, and health care systems because outcomes and costs are less predictable than primary THA. The purpose of this study was to define indications and treatments for rTHA, quantify risk for readmissions, and evaluate the economic impacts of rTHA in a hospital system. METHODS: The arthroplasty database of a hospital system was queried to generate a retrospective cohort of 793 rTHA procedures, performed on 518 patients, from 2017 to 2019 at 27 hospitals. Surgeons performed chart reviews to classify indication and revision procedure. Demographics, lengths of stay, discharge dispositions, and readmission data were collected. Analyses of direct costs were performed and categorized by revision type. RESULTS: Totally, 46.3% of patients presented for infection. Patients presenting for infection were 5.6 times more likely to have repeat rTHA than aseptic patients. Septic cases (4.3 days) had longer length of stay than aseptic ones (2.4) (P < .0001). However, 31% of patients discharged to a skilled nursing facility. Direct costs were greatest for a two-stage exchange ($37,642) and lowest for liner revision ($8,979). Septic revisions ($17,696) cost more than aseptic revisions ($11,204) (P < .0001). The 90-day readmission rate was 21.8%. Septic revisions had more readmissions (13.5%) than aseptic revisions (8.3%). CONCLUSIONS: Hip revisions, especially for infection, have an increased risk profile and create a major economic impact on hospital systems. Surgeons may use these data to counsel patients on risks of rTHA and advocate for improved reimbursement for the care of revision patients.
引用
- Duwelius PJ, Southgate RD, Crutcher JP, et al. Registry Data Show Complication Rates and Cost in Revision Hip Arthroplasty. J Arthroplasty. 2023. PMID: 37121489. doi:10.1016/j.arth.2023.04.050
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。